青色📘(@gyne112) 's Twitter Profile Photo

- NRG Oncology GY004 by Dr.Liu
- orapalib and cediranib(VEGFi)(both oral) for rec. platinum-sensitive ovarian ca.
- comperable progression-free survival to platinum based regimen

account_circle